Global Percutaneous Coronary Intervention Market: Information by Product Type (Coronary Stents, PTCA Catheters, Coronary Guidewire and Accessories), by End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Research and Academic Institutes and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2023
Competitive Dashboard:
Prominent players operating in the percutaneous coronary intervention market include Boston Scientific Corporation (U.S.), Abbott (U.S.), ASAHI INTECC Company Limited (Japan), C. R. Bard, Inc (U.S.), Comed B.V. (The Netherlands), Meril Lifesciences Pvt Ltd. (India), BIOTRONIK (U.S.), Medtronic Plc (U.S.), B. Braun Melsungen AG (Germany), Biosensors International Group, Ltd. (Singapore), Terumo Corporation (Japan), Cordis (U.S.), Cook Medical (U.S.), and Merit Medical System (U.S.).
Segmentation:
The Global Percutaneous Coronary Intervention Market has been segmented on the basis of product type and end-user.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3166
Various product types are segmented into coronary stents, percutaneous transluminal coronary angioplasty (PTCA) catheters, coronary guidewires, and accessories. Among these, the subsegment coronary Stent accounted for the largest share of 54% share in 2017. It was valued at USD 5452.5 million in the same year. It is further projected to grow at a CAGR of 7.81% during the forecast period.
By End-user, the market has been segmented into hospitals & specialty clinics, ambulatory surgical centers, research & academic institutes, and others. Out of these, the subsegment hospitals & specialty clinics accounted for 43% of the market share in 2017 and valued at USD 4,374.9 million. The subsegment is estimated to continue with its dominance registering a CAGR of 7.57% over the assessment period. The large share can be credited to the mushrooming of hospital chains amid increasing demands for quality patient care.
Strategic initiatives employed often involve mergers, acquisitions, product launches, and others. These tactical moves ensure individual company’s growth alongside the market’s expansion.
Regional Analysis:
The Global percutaneous coronary intervention market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. Among these, the Americas region dominates the market attributing to the increasing pool of awareness and the growing acceptability of percutaneous coronary intervention techniques.
The Europe Percutaneous Coronary Intervention Market is projected to register over 6% CAGR during the forecast period valued at approximately 4,600 Mn USD by 2023. The region assumed the second position in 2017 globally due to the rise in percutaneous coronary intervention centers in European countries. Furthermore, the increased number of hospitalizations for percutaneous coronary intervention procedures such as carotid artery angioplasty and cerebral angioplasty have been fostering the regional market.
The region accounted for almost 39% of the market share in 2017, followed by Europe accounting for 31% of the market share. Whereas, the Asia Pacific region can grow at a rapid clip mainly due to the increasing prevalence of cardiovascular diseases. The region had accounted for around 23% of the market share.
The Americas region dominates the global percutaneous coronary intervention market mainly due to the higher health care expenditures and the increasing prevalence of diseases such as cardiovascular and coronary artery disease. Factors such as well-spread awareness and the growing adoption of percutaneous coronary intervention techniques are driving the growth of the PCI market in the Americas.
In the US, percutaneous coronary intervention is one of the two most common procedures performed on patients with coronary artery disease. The US backed by the growing prevalence of cardiovascular angiography and interventions accounts for the major growth supporter to the regional market. The percutaneous coronary intervention market in the Americas is expected to reach USD 4,894.7 million by 2023.
The Percutaneous Coronary Intervention Market in the Asia Pacific region is expected to emerge as a promising market, growing rapidly due to the increasing prevalence of cardiovascular diseases, rapidly developing healthcare infrastructure, and improving economic conditions in the region. Simultaneously, the increasing number of research and development centers positively impacts the growth of this market.
Furthermore, owing to the factors such as the government initiatives of healthcare reforms and the increasing demand for advanced treatments in the region, the percutaneous coronary intervention market in the APAC will reach the valuation of USD 3,620.3 million by 2023.
Overview:
In recent years, the growing prevalence of chronic diseases related to heart, globally, the percutaneous coronary intervention market is growing at a rapid pace. Moreover, the increasing adoption of PCI procedures performed on patients with coronary artery disease is escalating the market constantly.
Percutaneous Coronary Intervention Market is a non-invasive procedure used to treat narrowing arteries of the heart in coronary artery diseases including angina, acute myocardial infarction, and multivessel coronary artery disease (CAD), among others. PCI procedure involving cardiac catheterization help in providing relief in the symptoms of coronary heart diseases and reduce damages to the heart after or during a heart attack.
Considering all these factors, the global percutaneous coronary intervention market is expected to reach over USD 15,205 million by 2023, growing at approximately 7.10% CAGR during the forecast period (2018-2023). The market stood at USD 10,160.9 million in 2017.
In addition to the growing prevalence of coronary heart diseases, the ever-increasing population worldwide and the increasing demand for the quality healthcare systems are factors expected to propel market volume till 2023.
Moreover, risk factors causing the heart-related diseases such as the increasing inclination towards the heady & sedentary lifestyle, and wrong eating habits, and changes in the social system over the last few years have been accelerating the market growth, increasing the incidents of the disease related to the heart.
However, the stringent government regulations for the approval of medical devices used in PCI alongside the lack of awareness towards the availability of percutaneous coronary intervention procedure may hinder the market growth over the forecast period. Also, the potential implications in diagnosis such as the infection caused during the procedure that can be challenging to diagnose and may have severe consequences are affecting the market growth.
Browse Detailed TOC at: https://www.marketresearchfuture.com/reports/percutaneous-coronary-intervention-market-3166
Brows More Healthcare Related Research Reports at:
Substance Abuse Treatment Market Research Report - Forecast to 2023 | MRFR
Impact of COVID-19 Outbreak on Healthcare Market
Cardiac Mapping Market Trends, Growth | Size Analysis, 2025
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]
OverviewThe rise in the number of cases that are being diagnosed with osteoarthritis has risen significantly in the past few years.
Increased investment from investors and market players is anticipated to unlock the growth potential of the marketRequest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1609SegmentationThe global osteoarthritis market has been segmented based on type, diagnosis, treatment, and end users.
The imaging segment, is sub-segmented into X-rays, magnetic resonance imaging (MRI), and others.
By end users, the osteoarthritis segment has been hospitals & clinics, medical institutes, research organization, and others.Industry Segments The osteoarthritis market globally is segmented on the basis of diagnosis, type, treatment, and end users.
The presence of a well-developed healthcare sector and the vast patient population suffering from osteoarthritis is a major driving force behind the growth of the regional market.
Western Europe holds a significant share of the regional market, which gets most of the contributions from Germany, France, and the UK.
Bile Duct Cancer Market Research Report, By Type (Intrahepatic, Extrahepatic), Diagnosis (Blood Tests, Abdominal Imaging, Surgery), By Treatment (Chemotherapy, Radiotherapy), By End User (Hospital& Clinics, Academic Institutes) - Global Forecast till 2027Market HighlightsBile duct cancer is a rare type of neoplasm in which epithelial cells of the bile duct are mutated and show epithelial differentiation.
However, high cost of treatment and related side effects along with low healthcare expenditures in the developing economies is expected restrain the market during the forecasted period.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4741SegmentationThe global bile duct cancer market is segmented on the basis of types, diagnosis, treatment, and end user.On the basis of types, the market is segmented into intrahepatic, extrahepatic, and others.On the basis of diagnosis, the market is segmented into blood tests, abdominal imaging, surgery, and others.
The diagnosis segment by abdominal imaging is sub segmented into endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC), magnetic resonance cholangiopancreatography (MRCP), and others.On the basis of treatment, the market is segmented into chemotherapy, radiotherapy, and others.
The chemotherapy segment is sub segmented into 5-fluorouracil, gemcitabine, cisplatin, and others.On the basis of end users, the market is segmented into hospital , academic institutes, research organizations and others.
Regional AnalysisThe Americas dominates the global bile duct cancer market owing to a well-developed healthcare sector.
According to the Centers for Disease Control and Prevention, U.S. health care spending in 2015, reached $3.2 trillion or $9,990 per person which accounted for 17.8% of the total GDP.
Anaplasmosis Treatment Market Research Report: By Species (Ixodes Scapularis, Ixodes Pacificus), Application (Humans, Livestock, Wildlife), Diagnosis (Elisa, Ifa, Pcr), By Treatment (Vaccine, Antibiotics), End User– Global Forecast till 2027Market HighlightsAnaplasmosis is a zoonotic disease affecting dogs, cats, livestock, wildlife, and human.
It is highly unlikely that a person will contract anaplasmosis from pets directly, but pets could bring ticks with the infection into home, posing a risk to the family.
If a pet is diagnosed with anaplasmosis, precautionary measures to reduce the risk of infection.
The disease is known as human granulocytic anaplasmosis (HGA) in people, canine granulocytic anaplasmosis in dogs, equine granulocytic anaplasmosis in horses, and tick-borne fever in ruminants.Favorable government policies for research and the presence of a large number of players in the global anaplasmosis treatment market are the key factors driving the growth of the market during the forecast period.Regional AnalysisGlobal anaplasmosis treatment consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East and Africa.The America is dominating the global anaplasmosis treatment market owing to the high prevalence rate of this disease in the eastern regions.
European holds the second largest share of the global anaplasmosis treatment market owing to the increasing research and development in biotechnology and pharmaceutical companies ,especially for study of diagnostic testing.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5351Asia Pacific is expected to be the fastest growing region and is anticipated to compete with the American market during the forecasted period 2017-2023.
The presence of anaplasmosis in India was first established early in the previous century and since then has been reported from almost all states.
Market HighlightsThe global medical vacuum systems market held a market value of USD 1,030.5 million in 2017 and is projected to grow at a CAGR of 7.1% over the forecast period.
Vacuum system maintains the pressure inside a chamber under the value of the atmospheric pressure.
A medical vacuum system provides a safe, adequate flow of vacuum, and the required pressure to be used in the healthcare facilities such as operating theaters (OTs), intensive care centers, and emergency and respirology/general medicine units.
Free sample copy is available here @ https://www.marketresearchfuture.com/sample_request/7569SegmentationThe global medical vacuum systems market has been segmented into product, technology, application, end user, and region.By product, the market has been segmented into standalone vacuum systems, centralized vacuum systems, portable and compact vacuum systems, and accessories.On the basis of technology, the market has been divided into dry claw vacuum pump technology, dry rotary vane technology, oil-sealed rotary vane technology, oil-sealed liquid ring technology, and water-sealed liquid ring technology.Based on application, the market has been categorized into therapeutic applications, diagnostic, research, and pharmaceutical, and biotechnology manufacturing.
The therapeutic applications segment is further categorized into wound care, dental, anesthesiology, and gynecology.By end user, the market has been categorized into hospitals, clinics, and surgery centers, pharmaceutical and biotechnology industries, diagnostic laboratories, and research and academic institutes.
Market Key PlayersSome of the spearheading players in the global medical vacuum systems market are Olympus Corporation, Atlas Copco AB, ZOLL Medical Corporation, Integra Biosciences AG, Ohio Medical Corporation, Precision Medical, Inc., Drägerwerk AG & Co. KGaA, Busch Holding GmbH, Medela Holding AG, BeaconMedæs, Gardner Denver, Inc., DEKKER Vacuum Technologies, Inc., Allied Healthcare Products, Inc., and Air Techniques, Inc.Browse the complete report @ https://www.marketresearchfuture.com/reports/medical-vacuum-systems-market-7569Intended AudienceMedical vacuum system manufacturers, dealers, and suppliersVenture capitalistsAssociation and government bodiesMarket research and consulting service providersHospitals and clinicsResearch and academic institutesCorporate entitiesAbout Market Research Future:MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients.
With the helps analytics of things, it is easy to analyze the huge data that the IoT devices are generating.The study indicates that Analytics of Things can help the enterprises in ensuring the devices connected to internet that is more efficient and smart.
However, the AoT are further integrated with information generated by IoT devices to monitor and compare.
Analytics of Things can be used in predictive analytics in various sectors including traffic, medical and manufacturing.The Analytics of Things Market is growing rapidly over 30.0% of CAGR and is expected to reach at USD $~29.53` billion by the end of forecast period.Taste the market data and market information presented through more than 30 market data tables and figures spread over 100 numbers of pages of the project report.
Avail the in-depth table of content TOC & market synopsis on “The Analytics of Things Market Research Report -Forecast to 2023”.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/analytics-of-things-market-3897 Analytics of Things Market SegmentationThe Analytics of Things Market has been segmented on the basis of type, component, end -users and region.
Europe is also expected to grow in the AoT market in the forthcoming years.The prominent players in the Analytics of Things market – Hewlett Packard Enterprise Company (US), Cisco Systems, Inc. (US), Dell Technologies, Inc. (US), Google, Inc., (US), Amazon Web Services (US), Salesforce.com, Inc. (US), Teradata Corporation (US), IBM Corporation (US), Microsoft Corporation (US), Oracle Corporation (US), SAP SE (Germany) among others.Market Research Analysis:On geographic basis, Analytics of Things market is studied in different regions as Americas, Europe, Asia-Pacific and Rest of world.
OverviewThe Global Intracranial Pressure Monitor Market is expected to exhibit a strong 7.1% CAGR over the forecast period from 2018 to 2024, according to the latest research report from Market Research Future (MRFR).
The global intracranial pressure monitoring market is mainly driven by the growing demand for noninvasive tools in the field of ICP monitoring and the increasing awareness about the importance of intracranial pressure monitoring in containing and managing neural and skeletal damage.Competitive Analysis:Leading players in the global intracranial pressure monitoring market include DePuy Synthes, Terumo Corporation, Spiegelberg GmbH & Co. KG, RAUMEDIC Inc., Boston Neurosciences, Medtronic plc, Integra LifeSciences Corporation, Sophysa SA, and Natus Medical Inc.In August 2019, Integra completed the acquisition of Arkis Biosciences, a leading player in the neurosurgery devices market.Regional Analysis:Americas held a dominant 41.4% share in the global intracranial pressure monitoring market in 2017 and are likely to hold on to the lead in the global intracranial pressure monitoring market over the forecast period due to the increasing demand for effective intracranial pressure monitoring devices in North America.
Widespread awareness about the importance of intracranial pressure monitoring in North America, particularly the U.S. and Canada, is likely to remain a major driver for the intracranial pressure monitoring market in the Americas over the forecast period.
Intracranial pressure monitoring is mainly used in the management of brain trauma and skeletal hemorrhage.
The rising prevalence of both these target conditions in North America is likely to remain a major driver for the intracranial pressure monitoring market in the region over the forecast period.Europe is also likely to hold a significant share in the global intracranial pressure monitoring market over the forecast period due to the increasing awareness about the process and the relevance of the monitoring in medical diagnosis and trauma management.
Intensive efforts at trauma control and management in European countries are likely to be a major driver for the intracranial pressure monitoring market in the region over the forecast period.
